IMCC IM Cannabis Corp.: Company Short-Term Debt

Corporate emblem and logo of IM Cannabis (IMCC)

IM Cannabis Corp. is developing a global distribution network for medical marijuana in Europe and Israel, minimizing regional threats through partnerships with farmers. The dynamics of current liabilities help assess the risk of a cash gap, while the 0.00 indicator determines the magnitude of the metric. The company is currently focusing on organic growth and stabilizing its market positions, having moved away from mergers. Recruiting leading agronomists ensures scientific progress.

IMC (IMCC) - Company Short-Term Loans and Borrowings from 07/04/2022 to 10/31/2026

Summary analytical data breakdowns for IM Cannabis Corp (IMCC)

- stock price and consensus target price:
Stock Price IMC|IMCC - Consensus Target
- company stock capitalization data:
Market Value IM Cannabis Corp.|IMCC - Total Enterprise Value
- shareholders' equity book value data:
Accounting Value per Share IM Cannabis|IMCC - Accounting Value of Company|Market Capitalization to Book Value Ratio imcannabis.com|IMCC - Total Asset Value of Company
- debt and liquidity details:
Total Debt to Capital IM Cannabis Corp.|IMCC - Long-Term Debt to Capital|Short-Term Debt to Equity IMC|IMCC - Aggregate Debt Obligations|Debt to Book Capitalization Ratio IM Cannabis Corp.|IMCC - Company Long-Term Liabilities|Company Short-Term Debts IM Cannabis|Quick Liquidity imcannabis.com
- earnings and valuation multiples indicators:
IMCC - Net Income
General company analysis:IMCC - imcannabis.com
Manufactured products of IMC

Amid stagnant scientific development, it is critical for IM Cannabis Corp. (IMCC) to manage liabilities with a maturity horizon of up to one year to avoid liquidity shortages given minimal R&D. A daily calculation analysis of current loans and borrowings allows for an assessment of interest expense risk and determines the company's ability to service short-term debt without compromising the operational stability of its assets.

Competitor analysis

Indivior - Company Short-Term Debts|Collegium Pharma (COLL) - Company Current Liabilities|Cronos (CRON) - Company Short-Term Debt|Short-Term Debt Canopy Growth Corp. (CGC)|Company Current Liabilities HITI|ACB: Company Short-Term Loans and Borrowings|Company Short-Term Debts ACHV|SKYE: Current Liabilities|Company Short-Term Debts ANEB (Anebulo)|Company Short-Term Debts InterCure Ltd INCR|NTRB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NSRX (Nasus Pharma Ltd)|igcinc.us (IGC) - Company Short-Term Debt|Company Current Liabilities MIRA Pharmaceuticals, Inc.|FLGC (Flora Growth Corporation) - Company Short-Term Debts|Adial (ADIL) - Short-Term Debt Volume|Company Short-Term Debt Artelo Biosciences (ARTL)|Company Current Liabilities ensysce.com ENSC|Titan Pharmaceuticals, Inc. - Company Current Liabilities|Company Short-Term Loans and Borrowings GNLN|InMed Pharma - Company Short-Term Debts|Akanda Inc (AKAN) - Company Current Liabilities|ENVB: Company Short-Term Debts|Bright Green Corporation (BGXX) - Company Short-Term Debts|Company Short-Term Debt Hempacco